{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:44:55Z","timestamp":1764402295633},"reference-count":13,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2004,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Three immunizations of mice with recombinant protective antigen (rPA) by transcutaneous immunization (TCI) induced long-term neutralizing antibody titers that were superior to those obtained with aluminum-adsorbed rPA. In addition, rPA alone exhibited adjuvant activity for TCI. Forty-six weeks after completion of TCI, 100% protection was observed against lethal anthrax challenge.<\/jats:p>","DOI":"10.1128\/iai.72.2.1181-1183.2004","type":"journal-article","created":{"date-parts":[[2004,1,24]],"date-time":"2004-01-24T23:46:23Z","timestamp":1074987983000},"page":"1181-1183","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":54,"title":["Needle-Free Skin Patch Vaccination Method for Anthrax"],"prefix":"10.1128","volume":"72","author":[{"given":"Gary R.","family":"Matyas","sequence":"first","affiliation":[{"name":"Department of Membrane Biochemistry, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur M.","family":"Friedlander","sequence":"additional","affiliation":[{"name":"U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory M.","family":"Glenn","sequence":"additional","affiliation":[{"name":"Iomai Corporation, Gaithersburg, Maryland 20878"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Little","sequence":"additional","affiliation":[{"name":"U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianmei","family":"Yu","sequence":"additional","affiliation":[{"name":"Iomai Corporation, Gaithersburg, Maryland 20878"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl R.","family":"Alving","sequence":"additional","affiliation":[{"name":"Department of Membrane Biochemistry, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00021-4"},{"key":"e_1_3_2_3_2","first-page":"33","volume":"271","year":"2002","unstructured":"Friedlander, A. M., S. L. Welkos, and B. E. Ivins. 2002. Anthrax vaccines. Curr. Top. Microbiol. Immunol.271:33-60.","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/82225"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2.2.253"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.4.1874-1880.2002"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(98)00008-8"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.59.6.1961-1965.1991"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","unstructured":"Joellenbeck L. M. L. L. Zwanziger J. S. Durch and B. L. Strom (ed.). 2002. The anthrax vaccine. Is it safe? Does it work? National Academy Press Washington D.C.","DOI":"10.21236\/ADA403352"},{"key":"e_1_3_2_10_2","first-page":"163","volume":"5","year":"1996","unstructured":"Matyas, G. R., and C. R. Alving. 1996. Protective prophylactic immunity against intranasal ricin challenge induced by liposomal ricin A subunit. Vaccine Res.5:163-172.","journal-title":"Vaccine Res."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00234-1"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00172-X"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.5.2888-2893.2001"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.9.5306-5313.2000"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.72.2.1181-1183.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.72.2.1181-1183.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T04:53:40Z","timestamp":1646456020000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.72.2.1181-1183.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["10.1128\/IAI.72.2.1181-1183.2004"],"URL":"https:\/\/doi.org\/10.1128\/iai.72.2.1181-1183.2004","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2]]},"assertion":[{"value":"2003-08-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-11-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}